share_log

Novo Nordisk Shares Are Trading Lower Following a Report Suggesting a Study Linked Ozempic to an Increased Risk of a Rare Form of Vision Loss.

Novo Nordisk Shares Are Trading Lower Following a Report Suggesting a Study Linked Ozempic to an Increased Risk of a Rare Form of Vision Loss.

諾和諾德的股票在一份報告公佈後下跌,該報告暗示一項研究將奧澤帕與一種罕見的視力喪失風險增加聯繫起來。
Benzinga ·  00:23

Novo Nordisk Shares Are Trading Lower Following a Report Suggesting a Study Linked Ozempic to an Increased Risk of a Rare Form of Vision Loss.

諾和諾德的股票在一份報告公佈後下跌,該報告暗示一項研究將奧澤帕與一種罕見的視力喪失風險增加聯繫起來。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論